NYU Abu Dhabi's SPIRAL Brain Implant Enhances Precision In Drug Delivery For Neurological Disorders

Researchers at New York University Abu Dhabi (NYUAD) have created a novel brain implant capable of delivering medication to various brain regions with precision. This innovation, named SPIRAL (Strategic Precision Infusion for Regional Administration of Liquid), is a slender, flexible tube designed to administer drugs at multiple points within the brain. This method allows access to larger and more intricate brain areas while keeping the implant minimally invasive.

Assistant Professor Khalil Ramadi, leading the research team at NYU Abu Dhabi and NYU Tandon, highlighted the limitations of current tools in targeting specific brain regions responsible for neurological disorders. "Neurological disorders often come from very specific regions of the brain, but our current tools for targeting these areas are limited," said Ramadi. "SPIRAL allows us to reach several regions at once without adding extra risk, which could change how we deliver therapy for these conditions."

Batoul Khlaifat, an NYUAD Research assistant and Co-Lead author, explained that SPIRAL addresses a significant issue with existing brain implants that typically deliver drugs from only one or two points. "SPIRAL makes it possible to distribute drugs more evenly and across larger regions, while still being safe and minimally invasive," she stated. This advancement enables broader drug distribution across the brain's tissue.

Mahmoud Elbeh, an NYUAD alum and current PhD candidate in Ramadi's lab, discussed the potential of SPIRAL in treating advanced diseases like glioblastoma. "When diseases like glioblastoma advance, treatment often means delivering drugs straight into a large volume of the brain to bypass the blood-brain barrier. Our helical form with tuned, evenly spaced outlets lets us cover more tissue from one insertion," he noted.

Elbeh further elaborated on how Computational Fluid Dynamics (CFD) was used to determine port sizes for consistent flow, creating a platform that might extend drug delivery applications to other solid organs. The adaptability of SPIRAL could also lead to its use in providing electrical stimulation or other advanced therapies.

The potential applications of SPIRAL extend beyond drug delivery. It could be adapted for electrical stimulation or other therapies beneficial for conditions like epilepsy and Parkinson’s disease. This versatility highlights its promise in treating various neurological disorders effectively.

This development represents a significant step forward in treating complex neurological conditions by offering a safer and more effective method of drug delivery directly into the brain.

With inputs from WAM